Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review, 79591 [2015-32018]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 245 / Tuesday, December 22, 2015 / Notices
79591
Prevention and the Agency for Toxic
Substances and Disease Registry.
Prevention and the Agency for Toxic
Substances and Disease Registry.
comments should be received within 30
days of this notice.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Catherine Ramadei,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–32014 Filed 12–21–15; 8:45 am]
[FR Doc. 2015–32018 Filed 12–21–15; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–18–P
Proposed Project
CDC Work@Health® Program: Phase 2
Training and Technical Assistance
Evaluation (OMB No. 0920–1006, exp.
date 1/31/2016)—Revision—National
Center for Chronic Disease Prevention
and Health Promotion (NCCDPHP),
Centers for Disease Control and
Prevention (CDC).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
[30Day–16–1006]
mstockstill on DSK4VPTVN1PROD with NOTICES
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the initial
review of applications in response to
Funding Opportunity (FOA) CK16–004,
Epicenters for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse
Events.
Time and Date: 10:00 a.m.–5:00 p.m.,
March 2–3, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section 552b(c)
(4) and (6), Title 5 U.S.C., and the
determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the initial review,
discussion, and evaluation of
applications received in response to
‘‘Epicenters for the Prevention of
Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse
Events’’, FOA CK16–004.
Contact Person For More Information:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, CDC, 1600
Clifton Road NE., Mailstop E60, Atlanta,
Georgia 30333, Telephone: (404) 718–
8833. The Director, Management
Analysis and Services Office, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
VerDate Sep<11>2014
17:21 Dec 21, 2015
Jkt 238001
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
Background and Brief Description
The Centers for Disease Control and
Prevention (CDC) is continuing to make
available the Work@Health® Program, a
comprehensive worksite health
promotion training program, to support
employers’ efforts to create healthy
work environments and provide
employees with opportunities to make
healthy lifestyle choices. The
Work@Health® Program will train and
support small, mid-size, and large
employers with three primary goals: (1)
Increase understanding of the training
needs of employers and the best way to
deliver skill-based training to them; (2)
Increase employers’ level of knowledge
and awareness of worksite health
program concepts and principles; and 3)
Increase the number of science-based
worksite health programs, policies, and
practices in place in participating
employers’ worksites resulting in
opportunities for employees to
participate in them.
CDC is requesting OMB approval to
continue Phase 2 information collection
with new cohorts of respondents in
2016–2019. Phase 2 procedures were
informed by a needs assessment and
pilot test that were conducted in fall
2013 (‘‘CDC Work@Health® Program:
Phase 1,’’ OMB No. 0920–0989, exp. 9/
30/2014) as well as first year results.
CDC will offer training in four models
(formats): (1) A ‘‘Hands-on’’ instructorled workshop model (T1), (2) a selfpaced ’’Online’’ model (T2), (3) a
combination or ‘‘Blended’’ model (T3),
and (4) a ‘‘Train-the-Trainer’’ model
(T4) designed to prepare qualified
individuals to train employers through
the Hands-on, Online, or Blended
models.
To evaluate the training, information
will be collected from approximately
480 employers and approximately 120
individuals who are interested in
becoming trained/certified instructors
for the Work@Health® Program. In
addition, information will be collected
from approximately 600 participant who
receive training delieverd by the
trained/certified instructors.
Respondents will include employers/
employees, trainees who participate in
E:\FR\FM\22DEN1.SGM
22DEN1
]]>Agencies
[Federal Register Volume 80, Number 245 (Tuesday, December 22, 2015)]
[Notices]
[Page 79591]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-32018]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP): Initial Review
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces a meeting for the initial review of
applications in response to Funding Opportunity (FOA) CK16-004,
Epicenters for the Prevention of Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse Events.
Time and Date: 10:00 a.m.-5:00 p.m., March 2-3, 2016 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the public in accordance with
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C.,
and the determination of the Director, Management Analysis and Services
Office, CDC, pursuant to Public Law 92-463.
Matters for Discussion: The meeting will include the initial
review, discussion, and evaluation of applications received in response
to ``Epicenters for the Prevention of Healthcare-Associated Infections,
Antimicrobial Resistance, and Adverse Events'', FOA CK16-004.
Contact Person For More Information: Gregory Anderson, M.S.,
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop
E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833. The Director,
Management Analysis and Services Office, has been delegated the
authority to sign Federal Register notices pertaining to announcements
of meetings and other committee management activities, for both the
Centers for Disease Control and Prevention and the Agency for Toxic
Substances and Disease Registry.
Catherine Ramadei,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-32018 Filed 12-21-15; 8:45 am]
BILLING CODE 4163-18-P
